AL23 Richard W. Weitzman Outstanding Early Career Investigator Award Lecture: Applying New Technologies to Conquer Hormone-Dependent Cancers

Program: Abstracts - Orals, Poster Previews, and Posters
Saturday, April 2, 2016: 11:30 AM-12:00 PM
Room 156 (BCEC)
To Be Determined and Diane M Robins, PhD, University of Michigan Medical School, Ann Arbor, MI

Nothing to Disclose: DMR Disclosure Not Provided: MRS, CAS
11:30 AM
Xiaole Shirley Liu, PhD, Department of Biostatistics, Dana Farber Cancer Institute/Harvard School of Public Health, Boston, MA


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire